Replies to post #142735 on Biotech Values

[mcbio]

In words, CDX-011 is not only the latest success in targeted therapy, it also stands to be the targeted cancer therapy with the broadest potential application. Consequently, the commercial potential of the drug could be beyond anything we have seen to date in the cancer market.

I like To's cautious optimism.